ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Drugs Winner
(
) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day up 0.9%. By the end of trading, ACADIA Pharmaceuticals rose $1.79 (9.7%) to $20.28 on average volume. Throughout the day, 5,425,644 shares of ACADIA Pharmaceuticals exchanged hands as compared to its average daily volume of 3,676,900 shares. The stock ranged in a price between $18.45-$20.43 after having opened the day at $18.67 as compared to the previous trading day's close of $18.49. Other companies within the Drugs industry that increased today were:
(
), up 15.1%,
(
), up 11.6%,
(
), up 9.4% and
Nymox Pharmaceutical Corporation
(
), up 9.2%.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. ACADIA Pharmaceuticals has a market cap of $1.6 billion and is part of the health care sector. Shares are up 299.1% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate ACADIA Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.
TheStreet Ratings rates ACADIA Pharmaceuticals as a
. Among the areas we feel are negative, one of the most important has been weak operating cash flow.
- You can view the full ACADIA Pharmaceuticals Ratings Report.
On the negative front,
(
), down 35.9%,
(
), down 6.9%,
(
), down 6.2% and
(
), down 6.1% , were all laggards within the drugs industry with
(
) being today's drugs industry laggard.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null